MS and COVID-19: Conflicting signs on risk but some trends are clearerJune 7, 2022COVID-19 UpdatesNeurology
Antidiabetes drug costs keep patients awayJune 6, 2022DiabetesBusiness of MedicineDiversity in Medicine
FDA denies petition to disqualify researchers over controversial ketamine studiesJune 6, 2022Health Policy
Increased social services spending ups cancer survival of BlacksJune 3, 2022Diversity in MedicineOncology
